MFG
PNT

Mendota Financial Group’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Mendota Financial Group’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$7 – 414
2023
Q3 		$7 Hold
1
– – ﹤0.01% 301
2023
Q2 		$10 Hold
1
– – ﹤0.01% 301
2023
Q1 		$8 Hold
1
– – ﹤0.01% 304
2022
Q4 		$7 Buy
+1
New +$7 ﹤0.01% 312

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Mendota Financial Group's PNT Position: Q4 2023 in Review

Mendota Financial Group sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 1 share — an estimated $7 sold.

Mendota Financial Group first reported a position in PNT in Q4 2022 and held it in 4 quarters. The position peaked at $10 in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Mendota Financial Group reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Mendota Financial Group sold 1 POINT Biopharma Global Inc. Common Stock share in Q4 2023, an estimated $7.
  • Mendota Financial Group first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • Mendota Financial Group's POINT Biopharma Global Inc. Common Stock position peaked at $10 in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Mendota Financial Group's 13F filing for Q4 2023, filed 19 Jan 2024.